Health
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet
BBV152 was highly efficacious against laboratory-confirmed symptomatic COVID-19 diseasein adults. Vaccination was well tolerated…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
General23 hours agoRyan Routh to face court charged with attempted assassination of Donald Trump
-
Noosa News18 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News18 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay
-
Noosa News19 hours agoBidding for a good cause